论文部分内容阅读
在本刊2001年12月的一期中,Gupta等曾经提出在结核病规划中是否应采购二线药治疗耐多药结核病(MDR—TB)的问题。他们的论文是在“tb.net”(www.tb.net.np)网上引发的一场争论后产生的。Gupta等集中在他们所提出的最重要的4点“概念”即:
In this issue of December 2001, Gupta et al. Proposed whether to purchase second-line drugs for MDR-TB in tuberculosis programs. Their essay came after a debate triggered online at “tb.net” (www.tb.net.np). Gupta, etc. focused on the four most important “concepts” that they proposed: